Provided by Tiger Trade Technology Pte. Ltd.

SHANDONG XINHUA

5.850
-0.180-2.99%
Volume:670.00K
Turnover:3.91M
Market Cap:4.08B
PE:13.93
High:6.060
Open:5.900
Low:5.805
Close:6.030
52wk High:7.748
52wk Low:5.029
Shares:697.00M
HK Float Shares:195.00M
Volume Ratio:1.43
T/O Rate:0.34%
Dividend:0.18
Dividend Rate:2.99%
EPS(LYR):0.420
ROE:4.99%
ROA:2.35%
PB:0.65
PE(LYR):13.93
PS:0.40

Loading ...

Xinhua Pharmaceutical's Q1 Profit Slides 25%

MT Newswires Live
·
Apr 28

山新华制药2025年营收微增、净利下滑,经营现金流显著改善

Bulletin Express
·
Apr 28

SHANDONG XINHUA Reports Q1 Net Profit of 83.9 Million Yuan, Down 25.15% Year-on-Year

Stock News
·
Apr 28

Xinhua Pharmaceutical Publishes 2025 ESG Report: Carbon-Peak Target Set for 2030, R&D Outlays Reach RMB 379.73 Million

Bulletin Express
·
Apr 28

Shandong Xinhua Initiates Full Electronic Distribution of Corporate Communications, Seeks Shareholders’ Email Details

Bulletin Express
·
Apr 28

Xinhua Pharmaceutical Gains MAH Status for Potassium Chloride Granules, Enters RMB 0.79 Billion Domestic Market

Bulletin Express
·
Apr 24

SHANDONG XINHUA Receives Approval Notice for Potassium Chloride Granules Supplemental Application

Stock News
·
Apr 24

CATL Shareholder Sets A-Share Transfer Price at 410.34 Yuan; Nitrogen Fertilizer Prices May Climb Further

Stock News
·
Apr 21

Shandong Xinhua to Convene 28 April 2026 Board Meeting for Q1 Results Review

Bulletin Express
·
Apr 15

SHANDONG XINHUA Receives Drug Registration Certificate for Bumetanide Injection

Stock News
·
Apr 15

SHANDONG XINHUA (00719) Secures Drug Registration Certificate for Concentrated Sodium Potassium Magnesium Calcium Injection

Stock News
·
Apr 07

Xinhua Pharmaceutical Gains NMPA Approval for Multi-Electrolyte Injection, Broadening Formulation Pipeline

Bulletin Express
·
Apr 07

Investors Can Find Comfort In Shandong Xinhua Pharmaceutical's (HKG:719) Earnings Quality

Simply Wall St.
·
Apr 06

Optical Chip Unicorn Xizhi Technology Files for Hong Kong IPO Amid Market Frenzy and Financial Challenges

Deep News
·
Apr 02

SHANDONG XINHUA secures NMPA approval to take over MAH for Galculus Bovis & Metronidazole Capsules

Bulletin Express
·
Apr 01

SHANDONG XINHUA (00719) Receives Approval Notice for Artificial Calculus Bovis and Metronidazole Capsules

Stock News
·
Apr 01

Board Reshuffle at SHANDONG XINHUA as Non-Executive Director Retires

Stock News
·
Mar 31

Shandong Xinhua Pharmaceutical: Non-Executive Director Xu Lie Steps Down Upon Retirement

Bulletin Express
·
Mar 31

Shandong Xinhua Pharmaceutical Reports Annual Results with 38.32% Drop in Net Profit

Stock News
·
Mar 27

Shandong Xinhua Pharmaceutical Announces RMB 0.15 Final Dividend for FY 2025

Bulletin Express
·
Mar 27